help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on May 29, 2008, doi:10.1164/rccm.200710-1486OC

Am. J. Respir. Crit. Care Med., Volume 178, Number 3, August 2008, 240-247

A more recent version of this article appeared on August 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200710-1486OCv1
178/3/240    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morissette, M. C
Right arrow Articles by Milot, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morissette, M. C
Right arrow Articles by Milot, J.

Submitted on October 8, 2007
Accepted on May 29, 2008

Increased p53 Level, Bax/BCL-XL Ratio, and TRAIL Receptors Expression in Human Emphysema

Mathieu C Morissette1, Guillaume Vachon-Beaudoin1, Julie Parent1, Jamila Chakir1, and Julie Milot1*

1 Centre de Recherche de l'Hopital Laval, Institut universitaire de Cardiologie et de Pneumologie de l'Universite Laval, Sainte-Foy, Quebec, Canada

* To whom correspondence should be addressed. E-mail: julie.milot{at}crhl.ulaval.ca.

Rationale: Emphysema is mainly known for the complex inflammatory processes associated with its development. In addition to lung inflammation, it is now accepted that increased alveolar cell apoptosis is also part of emphysema pathophysiology. However, little is known about the mechanisms involved in alveolar apoptosis. We postulate that oxidative stress and pro-inflammatory cytokines could lead to p53 accumulation, Bax/Bcl-xL ratio elevation and higher TNF-related apoptosis-inducing ligand (TRAIL) receptor levels in the emphysematous lung. Objectives: To evaluate the expression of p53, Bax, Bcl-xL, TRAIL, and TRAIL receptors in lung parenchyma from non-emphysematous non-smokers and smokers and emphysematous smokers and ex-smokers and to determine whether hydrogen peroxide (H2O2) and/or TNF can modulate the expression of these apoptotic proteins. Methods: p53, Bax, Bcl-xL, and TRAIL receptor protein levels in lung parenchyma were measured by Western blot and TRAIL mRNA levels were measured by real-time PCR. Changes in TRAIL receptor, Bax, Bcl-xL, and p53 protein levels following in vitro H2O2 and/or TNF stimulation of A549 cells were also assessed by Western blot. Main Results: p53 protein levels, the Bax/Bcl-xL ratio, and TRAIL-R1, R2, R3 protein levels were significantly higher in subjects with emphysema. Moreover, they were also increased following H2O2 and TNF treatments of A549 cells. Conclusions: These findings suggest that oxidative stress and pro-inflammatory cytokines may be involved in the elevation of p53 levels, the Bax/Bcl-xL ratio, and TRAIL receptor levels, new mechanisms that may be implicated in the increased alveolar cell apoptosis that occurs in emphysema.


Key words: COPD, cell death, oxidative stress, inflammation




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
J. D Maclay, R. A Rabinovich, and W. MacNee
Update in Chronic Obstructive Pulmonary Disease 2008
Am. J. Respir. Crit. Care Med., April 1, 2009; 179(7): 533 - 541.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2008 American Thoracic Society
  The ATS Has Opened Search for New PATS Editor